arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ADMA BIOLOGICS, INC.

ADMA

$13.21 ▼ -0.78 (-5.58%) at close

16 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

ADMA BIOLOGICS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $3.1B

Dividend Yield —

Revenue Growth 19.6% ↘

Op. Margin 37.5% ↗

ROIC 28.0% ↘

FCF / Share $0.12 ↘

Trailing P/E 21.3x

Price / Book 6.6x

FCF Yield 0.9%

Debt / Equity 0.15

info Valuation on last close. End-of-day price, Nov 5, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$510.17M

↑ +19.6% —

Net Income Profit after all expenses

$146.93M

↓ -25.7% —

Operating Margin Operating profit as % of sales

37.5%

↑ +15.1% 92th

FCF / Share Free cash flow per share

$0.12

↓ -75.4% —

Long-Term Debt Long-term obligations

$72.14M

— -0.3% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Operating Margin (%)Operating Margin (%) is in the top quartile
Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability

Returns

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	19.6% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+145%)	65.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+714%)	67.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+745%)	90.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1029%)	91.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1046%)	43.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+448%)	72.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+810%)	-25.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-417%)	113.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1319%)	48.5% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+507%)	21.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+167%)	92.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1061%)	174.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2079%)	46.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+486%)	—	—
EPS Growth YoY (%)	-27.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	60.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	42.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-25.7% Weak ↓ Weak Declining Year-over-year change in net income	N/M	57.2% Excellent ↑ Excellent Improving Year-over-year change in net income	8.0% Fair ↑ Fair Improving Year-over-year change in net income	5.4% Fair ↑ Fair Improving Year-over-year change in net income	-56.9% Weak ↓ Weak Declining Year-over-year change in net income	26.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-50.2% Weak ↓ Weak Declining Year-over-year change in net income	-124.2% Weak ↓ Weak Declining Year-over-year change in net income	-8.6% Weak ↑ Weak Improving Year-over-year change in net income	-6.9% Weak ↑ Weak Improving Year-over-year change in net income	-8.3% Weak ↑ Weak Improving Year-over-year change in net income	-112.7% Weak Weak Year-over-year change in net income	-23.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-75.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	2534.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	N/M	58.9% Excellent Excellent Year-over-year change in free cash flow	32.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	49.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	74.0% Excellent → Excellent Stable Compound annual revenue growth over 3 years	82.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	73.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	68.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	22.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	40.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	33.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	56.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	51.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	85.9% Excellent Excellent Compound annual revenue growth over 3 years	98.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	64.6% Excellent → Excellent Stable Compound annual revenue growth over 5 years	70.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	72.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	46.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	50.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	42.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	37.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	40.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	82.7% Excellent Excellent Compound annual revenue growth over 5 years	69.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	37.5% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+150%)	32.6% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+117%)	8.4% Caution ↑ Caution Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-44%)	-25.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-270%)	-72.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-581%)	-153.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1125%)	-141.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1041%)	-354.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2466%)	-172.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1251%)	-162.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1184%)	-216.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1541%)	-270.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1905%)	-490.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3369%)	—	—	—
Effective Tax Rate (%) (%)	19.6% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-57.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	28.8% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+140%)	46.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+286%)	-10.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-191%)	-42.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-456%)	-88.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-838%)	-179.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1595%)	-164.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1471%)	-387.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3326%)	-192.3% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1702%)	-183.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1625%)	-250.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2186%)	-284.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2469%)	—	—	—	—
FCF Margin (%) (%)	5.5% Caution ↑ Caution Improving Free cash flow as a percentage of revenue Optimal: > 10%	25.9% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	1.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-47.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-155.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-271.7% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-272.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-381.4% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-175.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-172.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-215.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-287.9% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-361.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-188.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.76x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.66x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.24x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	28.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	51.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	16.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-58.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-124.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-211.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-72.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	513.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1889.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-258.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-69.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-77.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-946.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	30.7% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	28.4% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	6.6% Caution ↑ Caution Improving Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-67.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-65.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-158.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	30.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+105%)	56.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+278%)	-20.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-239%)	-43.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-389%)	-50.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-438%)	-85.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-672%)	-184.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1329%)	—	-108.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-823%)	—	—	-279.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1965%)	-72.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-580%)	-77.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-617%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Debt to Equity (x)	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	0.21x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-65%)	—	—	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.14x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-77%)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-89%)	-0.40x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-167%)	—	—	—	—	—	—
Interest Coverage (x)	21.09x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	13.03x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	1.20x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.04x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-10.92x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-11.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-257.77x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-15.49M	$-30.81M	$-51.35M	$-86.52M	$-51.09M	$-55.92M	$-26.75M	$-19.99M	$-40.35M	$-8.12M	$-10.44M	$-17.20M	$-26.15M	$-12.54M	$-87.77K	$-228.97K
Debt / EBITDA (x)	0.36x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	0.49x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.07x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$2.14	$1.83	$1.15	$0.78	$0.58	$0.49	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$0.62	$0.85	$-0.13	$-0.33	$-0.51	$-0.88	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$0.12	$0.47	$0.02	$-0.37	$-0.90	$-1.33	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.01	$1.48	$0.60	$0.69	$0.72	$0.84	$0.44	$0.43	$1.10	$-0.35	$0.08	$0.65	$2.32	$1.61	$0.94	—
Tangible Book Value per Share (USD)	$1.99	$1.46	$0.58	$0.66	$0.69	$0.78	$0.33	$0.26	$0.87	$-0.35	$0.08	$0.65	$2.32	$1.61	$0.94	—
Basic Weighted Avg Shares (shares)	238.30M	233.08M	223.98M	197.87M	139.58M	86.15M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Working Capital (USD)	$396.97M	$275.87M	$207.21M	$231.13M	$178.35M	$133.79M	$71.79M	$34.90M	$53.73M	$10.43M	$17.07M	$19.89M	$27.39M	$12.13M	$-1.01M	—
LT Debt (USD)	$72.14M	$72.34M	—	—	—	—	$0.00	$2.76M	$2.76M	$1.79M	—	—	—	—	—	—
Total Equity (USD)	$477.32M	$349.02M	$135.21M	$151.97M	$141.17M	$88.25M	$26.19M	$19.77M	$40.33M	$-4.46M	$820.97K	$6.01M	$21.57M	$9.42M	$385.82K	$-3.93M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$510.17M	$426.45M	$258.21M	$154.08M	$80.94M	$42.22M	$29.35M	$16.99M	$22.76M	$10.66M	$7.18M	$5.92M	$3.07M	$1.12M	$761.04K	—
Depreciation Expense (USD)	$8.00M	$7.70M	$7.60M	$6.40M	$4.80M	$3.20M	$2.40M	$2.60M	$1.50M	$400.00K	$469.82K	$247.85K	$210.63K	—	—	—
Net Income, GAAP (USD)	$146.93M	$197.67M	$-28.24M	$-65.90M	$-71.65M	$-75.75M	$-48.28M	$-65.74M	$-43.76M	$-19.52M	$-17.97M	$-16.81M	$-15.53M	$-7.30M	$-5.90M	—
Operating Cash Flow (USD)	$50.40M	$118.67M	$8.80M	$-59.51M	$-112.37M	$-102.00M	$-76.19M	$-62.68M	$-37.27M	$-18.27M	$-15.42M	$-14.70M	$-10.89M	$-6.90M	$-1.43M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 16 years · 73 quarters

ADMA BIOLOGICS, INC.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ADMA with peers